WebJan 22, 2024 · The Court of Appeal gave judgment in Competition and Markets Authority v Flynn Pharma and Pfizer in May 2024, effectively adjusting the starting point for costs awards following successful appeals of Competition and Markets Authority (CMA) decisions. WebApr 2, 2024 · 7 Competition and Markets Authority v. Flynn Pharma Limited, Pfizer Inc & Ors [2024] EWCA Civ 339. 8 The Court of Appeal did accept the CMA’s argument that – contrary to the finding made by the CAT– the CMA is not required to identify a hypothetical benchmark price. 9 CMA v. Flynn and Pfizer, Court of Appeal costs judgment (fn 1).
Lorna Brazell on LinkedIn: Law Commission hits pause on smart …
WebJul 25, 2024 · PERMISSION TO APPEAL. 17.A judgment of the Tribunal in a case such as this can be challenged under section 49 CA98, which provides for appeals to the Court of Appeal. Any such appeal requires the permission of this Tribunal or the Court of Appeal and must either be as to the amount of any penalty, or be on a point of law. WebJun 7, 2024 · Pfizer and Flynn were each found to have infringed the Chapter II prohibition under the Competition Act 1998 (“CA 98”) and Article 102 of the Treaty on the … cam reddish position
Judgment Competition Appeal Tribunal
WebOct 4, 2024 · Pfizer and Flynn appealed against the Decision to the Competition Appeal Tribunal ("the Tribunal"). The appeal was heard during October and November 2024. Judgment was handed down on 7th June 2024 and … WebMar 12, 2024 · Court of Appeal Judgment confirms that Pfizer and Flynn should not yet be fined for excessive pricing of anti-epilepsy drug. In a key competition case in the … WebAug 16, 2024 · Flynn Pharma is pleased to receive the judgment of the Court of Appeal regarding the CMA’s phenytoin investigation. This case is approaching its seventh anniversary, notwithstanding that Flynn had clearly set out its position and logic from the earliest days of the case. fish and chip shop brampton